Skip to main content
. 1998 Feb;72(2):1210–1218. doi: 10.1128/jvi.72.2.1210-1218.1998

TABLE 1.

Selection of WIN 52035-dependent mutants of HRV16

Isolate no. Relative plaquing efficiencya
1st plaquing 2nd plaquing 3rd plaquing
1 23 220 1,300
2 6 70 3,200
3 29 1,800 5,000
4 44 8,000 10,000
5 280 290 850
6 70 2,500 6,000
7 210 11,000 5,000
8 110 3,200 10,000
9 17 110 6,000
a

Defined as the plaque titer in the presence of 2 μg of WIN 52035 per ml divided by that in the absence of the drug.